Cargando…

Disseminated Mycobacterium abscessus infection and native valve endocarditis

Mycobacterium abscessus is a rapidly growing mycobacterium. It rarely causes disseminated infection or endocarditis. A 55-year-old male with a history of hepatitis C, liver cirrhosis, intravenous drug use (last use was four years ago), and chronic back pain presented with a three-week history of a r...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahi, Mandeep Singh, Reyes, Sandra Patrucco, Parekh, Jay, Gunasekaran, Kulothungan, Amoah, Kwesi, Rudolph, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7804832/
https://www.ncbi.nlm.nih.gov/pubmed/33489744
http://dx.doi.org/10.1016/j.rmcr.2020.101331
_version_ 1783636192417284096
author Rahi, Mandeep Singh
Reyes, Sandra Patrucco
Parekh, Jay
Gunasekaran, Kulothungan
Amoah, Kwesi
Rudolph, Daniel
author_facet Rahi, Mandeep Singh
Reyes, Sandra Patrucco
Parekh, Jay
Gunasekaran, Kulothungan
Amoah, Kwesi
Rudolph, Daniel
author_sort Rahi, Mandeep Singh
collection PubMed
description Mycobacterium abscessus is a rapidly growing mycobacterium. It rarely causes disseminated infection or endocarditis. A 55-year-old male with a history of hepatitis C, liver cirrhosis, intravenous drug use (last use was four years ago), and chronic back pain presented with a three-week history of a right calf nodular lesion. He did not have a fever, chills, rash, dyspnea, or cough. Laboratory data showed mild leukocytosis. Computed tomography of the chest revealed bilateral cavitating nodules. Skin biopsy, sputum, and blood cultures grew Mycobacterium abscessus. Therapy with meropenem, tigecycline, and amikacin was initiated. He was re-admitted with worsening lower back pain. A lumbar magnetic resonance imaging showed destructive changes of L4 and L5 vertebral bodies concerning for osteomyelitis. Blood culture and bone biopsy grew Mycobacterium abscessus again. An echocardiogram was performed due to persistent bacteremia, which revealed large vegetation on the tricuspid valve and small vegetation on the mitral valve. Therapy was changed to eight weeks of amikacin, with cefoxitin and imipenem for twelve months based on drug susceptibility. Treatment of disseminated Mycobacterium abscessus is challenging due to antibiotic resistance. Typically, multidrug therapy is warranted with at least three active drugs. In severe valvular endocarditis, valve replacement may be required.
format Online
Article
Text
id pubmed-7804832
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-78048322021-01-22 Disseminated Mycobacterium abscessus infection and native valve endocarditis Rahi, Mandeep Singh Reyes, Sandra Patrucco Parekh, Jay Gunasekaran, Kulothungan Amoah, Kwesi Rudolph, Daniel Respir Med Case Rep Case Report Mycobacterium abscessus is a rapidly growing mycobacterium. It rarely causes disseminated infection or endocarditis. A 55-year-old male with a history of hepatitis C, liver cirrhosis, intravenous drug use (last use was four years ago), and chronic back pain presented with a three-week history of a right calf nodular lesion. He did not have a fever, chills, rash, dyspnea, or cough. Laboratory data showed mild leukocytosis. Computed tomography of the chest revealed bilateral cavitating nodules. Skin biopsy, sputum, and blood cultures grew Mycobacterium abscessus. Therapy with meropenem, tigecycline, and amikacin was initiated. He was re-admitted with worsening lower back pain. A lumbar magnetic resonance imaging showed destructive changes of L4 and L5 vertebral bodies concerning for osteomyelitis. Blood culture and bone biopsy grew Mycobacterium abscessus again. An echocardiogram was performed due to persistent bacteremia, which revealed large vegetation on the tricuspid valve and small vegetation on the mitral valve. Therapy was changed to eight weeks of amikacin, with cefoxitin and imipenem for twelve months based on drug susceptibility. Treatment of disseminated Mycobacterium abscessus is challenging due to antibiotic resistance. Typically, multidrug therapy is warranted with at least three active drugs. In severe valvular endocarditis, valve replacement may be required. Elsevier 2021-01-01 /pmc/articles/PMC7804832/ /pubmed/33489744 http://dx.doi.org/10.1016/j.rmcr.2020.101331 Text en © 2020 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Rahi, Mandeep Singh
Reyes, Sandra Patrucco
Parekh, Jay
Gunasekaran, Kulothungan
Amoah, Kwesi
Rudolph, Daniel
Disseminated Mycobacterium abscessus infection and native valve endocarditis
title Disseminated Mycobacterium abscessus infection and native valve endocarditis
title_full Disseminated Mycobacterium abscessus infection and native valve endocarditis
title_fullStr Disseminated Mycobacterium abscessus infection and native valve endocarditis
title_full_unstemmed Disseminated Mycobacterium abscessus infection and native valve endocarditis
title_short Disseminated Mycobacterium abscessus infection and native valve endocarditis
title_sort disseminated mycobacterium abscessus infection and native valve endocarditis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7804832/
https://www.ncbi.nlm.nih.gov/pubmed/33489744
http://dx.doi.org/10.1016/j.rmcr.2020.101331
work_keys_str_mv AT rahimandeepsingh disseminatedmycobacteriumabscessusinfectionandnativevalveendocarditis
AT reyessandrapatrucco disseminatedmycobacteriumabscessusinfectionandnativevalveendocarditis
AT parekhjay disseminatedmycobacteriumabscessusinfectionandnativevalveendocarditis
AT gunasekarankulothungan disseminatedmycobacteriumabscessusinfectionandnativevalveendocarditis
AT amoahkwesi disseminatedmycobacteriumabscessusinfectionandnativevalveendocarditis
AT rudolphdaniel disseminatedmycobacteriumabscessusinfectionandnativevalveendocarditis